Vaccination for meningococcal disease
In the European Union, multiple vaccines are authorised for use to protect against some types (serogroups) of meningococcal bacteria.
Vaccine safety and effectiveness
This document provides an overview of the two meningococcal B vaccines evaluated by the European Medicines Agency (EMA) to prevent invasive meningococcal disease (IMD) caused by Neisseria meningitidis group B. It also explains the scientific evidence supporting the vaccines’ safety and effectiveness. It aims to support healthcare professionals’ discussions with parents and carers.
Immunisation & childhood vaccination
